Gene Activity List

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Gene Compound Experiment Study Pathway Assay Report Bug Request Feature
Gene Activity List
You are on Page 24 of 50:
14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34
Gene Compound Assay Inh Ic50 Ki View
sodium channel, nonvoltage-gated 1 gamma BENZTROPINE Sodium Channel, Site 2 88% 1.68uM 1.533uM View
sodium channel, nonvoltage-gated 1 beta BENZTROPINE Sodium Channel, Site 2 88% 1.68uM 1.533uM View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide BENZTROPINE Sodium Channel, Site 2 88% 1.68uM 1.533uM View
sodium channel, voltage-gated, type XI, alpha BENZTROPINE Sodium Channel, Site 2 88% 1.68uM 1.533uM View
sodium channel, nonvoltage-gated 1, gamma BENZTROPINE Sodium Channel, Site 2 88% 1.68uM 1.533uM View
sodium channel, nonvoltage-gated 1, delta BENZTROPINE Sodium Channel, Site 2 88% 1.68uM 1.533uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) BENZTROPINE Sodium Channel, Site 2 88% 1.68uM 1.533uM View
sodium channel, nonvoltage-gated 1 alpha BENZTROPINE Sodium Channel, Site 2 88% 1.68uM 1.533uM View
sodium channel, voltage-gated, type X, alpha BENZTROPINE Sodium Channel, Site 2 88% 1.68uM 1.533uM View
sodium channel, voltage-gated, type IX, alpha BENZTROPINE Sodium Channel, Site 2 88% 1.68uM 1.533uM View
sodium channel, voltage gated, type VIII, alpha BENZTROPINE Sodium Channel, Site 2 88% 1.68uM 1.533uM View
sodium channel, voltage-gated, type VII, alpha BENZTROPINE Sodium Channel, Site 2 88% 1.68uM 1.533uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) BENZTROPINE Sodium Channel, Site 2 88% 1.68uM 1.533uM View
sodium channel, voltage-gated, type IV, beta BENZTROPINE Sodium Channel, Site 2 88% 1.68uM 1.533uM View
sodium channel, voltage-gated, type IV, alpha BENZTROPINE Sodium Channel, Site 2 88% 1.68uM 1.533uM View
sodium channel, voltage-gated, type III, alpha BENZTROPINE Sodium Channel, Site 2 88% 1.68uM 1.533uM View
sodium channel, voltage-gated, type II, beta BENZTROPINE Sodium Channel, Site 2 88% 1.68uM 1.533uM View
sodium channel, voltage-gated, type II, alpha 2 BENZTROPINE Sodium Channel, Site 2 88% 1.68uM 1.533uM View
sodium channel, voltage-gated, type I, beta BENZTROPINE Sodium Channel, Site 2 88% 1.68uM 1.533uM View
sodium channel, voltage-gated, type I, alpha BENZTROPINE Sodium Channel, Site 2 88% 1.68uM 1.533uM View
sodium channel, voltage-gated, type IV, beta BENZTROPINE Sodium Channel, Site 2 88% 1.68uM 1.533uM View
sodium channel associated protein 1 BENZTROPINE Sodium Channel, Site 2 88% 1.68uM 1.533uM View
sodium channel associated protein 2 BENZTROPINE Sodium Channel, Site 2 88% 1.68uM 1.533uM View
sodium channel, voltage-gated, type III, beta BENZTROPINE Sodium Channel, Site 2 88% 1.68uM 1.533uM View
sodium channel, voltage-gated, type I, alpha BENZTROPINE Sodium Channel, Site 2 88% 1.68uM 1.533uM View
dopamine receptor D4 HALOPERIDOL Dopamine D4.2 87% .563uM .198uM View
adrenergic receptor, alpha 2b HALOPERIDOL Adrenergic alpha2B 87% 1.354uM .618uM View
dopamine receptor D1A GENTIAN VIOLET Dopamine D1 87% 3.102uM 1.551uM View
cholinergic receptor, muscarinic 4 MIANSERIN Muscarinic M4 87% 2.066uM .288uM View
histamine receptor H 2 MIANSERIN Histamine H2 87% 1.008uM .992uM View
Cytochrom P450-2D6 monooxygenase LYSERGOL CYP450-2D6 Inhibition 87% 1uM NoneNone View
dopamine receptor 2 METHYSERGIDE Dopamine D2L 87% .807uM .269uM View
mitogen activated protein kinase 14 1-(2-METHOXYBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE Protein Serine/Threonine Kinase, p38alpha 87% .746uM NoneNone View
mitogen-activated protein kinase 14 1-(2-METHOXYBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE Protein Serine/Threonine Kinase, p38alpha 87% .746uM NoneNone View
prostaglandin-endoperoxide synthase 2 ETODOLAC Cyclooxygenase COX-2 87% .561uM NoneNone View
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) ETODOLAC Cyclooxygenase COX-2 87% .561uM NoneNone View
5-hydroxytryptamine (serotonin) receptor 2B LORATADINE Serotonin 5-HT2B 86% .245uM .156uM View
mitogen activated protein kinase 14 1-(2-FLUOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE Protein Serine/Threonine Kinase, p38alpha 86% .537uM NoneNone View
mitogen-activated protein kinase 14 1-(2-FLUOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE Protein Serine/Threonine Kinase, p38alpha 86% .537uM NoneNone View
A3 adenosine receptor 1-NAPHTHYL ISOTHIOCYANATE Adenosine A3 86% 6.1uM 3.448uM View
acetylcholinesterase (YT blood group) IRINOTECAN Acetylcholinesterase 86% 1.827uM NoneNone View
collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase IRINOTECAN Acetylcholinesterase 86% 1.827uM NoneNone View
acetylcholinesterase IRINOTECAN Acetylcholinesterase 86% 1.827uM NoneNone View
dopamine receptor D1A KETOTIFEN Dopamine D1 86% .872uM .436uM View
opioid receptor, kappa 1 SAQUINAVIR Opiate kappa 86% 6.951uM 2.78uM View
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) RITONAVIR CYP450-2C9 Inhibition 86% .016uM NoneNone View
cytochrome P450, family 2, subfamily C, polypeptide 9 RITONAVIR CYP450-2C9 Inhibition 86% .016uM NoneNone View
5-hydroxytryptamine (serotonin) receptor 3a OLANZAPINE Serotonin 5-HT3 86% 1.316uM .296uM View
5-hydroxytryptamine (serotonin) receptor 3b OLANZAPINE Serotonin 5-HT3 86% 1.316uM .296uM View
sodium channel, voltage-gated, type IV, beta ORPHENADRINE Sodium Channel, Site 2 86% 2.492uM 2.274uM View
sodium channel associated protein 1 ORPHENADRINE Sodium Channel, Site 2 86% 2.492uM 2.274uM View
sodium channel associated protein 2 ORPHENADRINE Sodium Channel, Site 2 86% 2.492uM 2.274uM View
sodium channel, voltage-gated, type III, beta ORPHENADRINE Sodium Channel, Site 2 86% 2.492uM 2.274uM View
sodium channel, voltage-gated, type I, alpha ORPHENADRINE Sodium Channel, Site 2 86% 2.492uM 2.274uM View
sodium channel, voltage-gated, type IX, alpha ORPHENADRINE Sodium Channel, Site 2 86% 2.492uM 2.274uM View
sodium channel, voltage-gated, type VII, alpha ORPHENADRINE Sodium Channel, Site 2 86% 2.492uM 2.274uM View
amiloride-sensitive cation channel 5, intestinal ORPHENADRINE Sodium Channel, Site 2 86% 2.492uM 2.274uM View
sodium channel, voltage-gated, type III, beta ORPHENADRINE Sodium Channel, Site 2 86% 2.492uM 2.274uM View
sodium channel, voltage-gated, type VIII, alpha polypeptide ORPHENADRINE Sodium Channel, Site 2 86% 2.492uM 2.274uM View
sodium channel, voltage-gated, type XI, alpha ORPHENADRINE Sodium Channel, Site 2 86% 2.492uM 2.274uM View
sodium channel, voltage-gated, type I, beta ORPHENADRINE Sodium Channel, Site 2 86% 2.492uM 2.274uM View
sodium channel, voltage-gated, type 10, alpha polypeptide ORPHENADRINE Sodium Channel, Site 2 86% 2.492uM 2.274uM View
sodium channel, voltage-gated, type IV, alpha polypeptide ORPHENADRINE Sodium Channel, Site 2 86% 2.492uM 2.274uM View
sodium channel, voltage-gated, type V, alpha polypeptide ORPHENADRINE Sodium Channel, Site 2 86% 2.492uM 2.274uM View
sodium channel, voltage-gated, type II, beta ORPHENADRINE Sodium Channel, Site 2 86% 2.492uM 2.274uM View
sodium channel, nonvoltage-gated 1 alpha ORPHENADRINE Sodium Channel, Site 2 86% 2.492uM 2.274uM View
sodium channel, nonvoltage-gated 1 gamma ORPHENADRINE Sodium Channel, Site 2 86% 2.492uM 2.274uM View
sodium channel, nonvoltage-gated 1 beta ORPHENADRINE Sodium Channel, Site 2 86% 2.492uM 2.274uM View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide ORPHENADRINE Sodium Channel, Site 2 86% 2.492uM 2.274uM View
sodium channel, voltage-gated, type XI, alpha ORPHENADRINE Sodium Channel, Site 2 86% 2.492uM 2.274uM View
sodium channel, nonvoltage-gated 1, gamma ORPHENADRINE Sodium Channel, Site 2 86% 2.492uM 2.274uM View
sodium channel, nonvoltage-gated 1, delta ORPHENADRINE Sodium Channel, Site 2 86% 2.492uM 2.274uM View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) ORPHENADRINE Sodium Channel, Site 2 86% 2.492uM 2.274uM View
sodium channel, nonvoltage-gated 1 alpha ORPHENADRINE Sodium Channel, Site 2 86% 2.492uM 2.274uM View
sodium channel, voltage-gated, type X, alpha ORPHENADRINE Sodium Channel, Site 2 86% 2.492uM 2.274uM View
sodium channel, voltage-gated, type IX, alpha ORPHENADRINE Sodium Channel, Site 2 86% 2.492uM 2.274uM View
sodium channel, voltage gated, type VIII, alpha ORPHENADRINE Sodium Channel, Site 2 86% 2.492uM 2.274uM View
sodium channel, voltage-gated, type VII, alpha ORPHENADRINE Sodium Channel, Site 2 86% 2.492uM 2.274uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) ORPHENADRINE Sodium Channel, Site 2 86% 2.492uM 2.274uM View
sodium channel, voltage-gated, type IV, beta ORPHENADRINE Sodium Channel, Site 2 86% 2.492uM 2.274uM View
sodium channel, voltage-gated, type IV, alpha ORPHENADRINE Sodium Channel, Site 2 86% 2.492uM 2.274uM View
sodium channel, voltage-gated, type III, alpha ORPHENADRINE Sodium Channel, Site 2 86% 2.492uM 2.274uM View
sodium channel, voltage-gated, type II, beta ORPHENADRINE Sodium Channel, Site 2 86% 2.492uM 2.274uM View
sodium channel, voltage-gated, type II, alpha 2 ORPHENADRINE Sodium Channel, Site 2 86% 2.492uM 2.274uM View
sodium channel, voltage-gated, type I, beta ORPHENADRINE Sodium Channel, Site 2 86% 2.492uM 2.274uM View
sodium channel, voltage-gated, type I, alpha ORPHENADRINE Sodium Channel, Site 2 86% 2.492uM 2.274uM View
Cytochrom P450-2D6 monooxygenase BUPIVACAINE HYDROCHLORIDE CYP450-2D6 Inhibition 86% .4uM NoneNone View
calcium channel, voltage-dependent, beta 1 subunit U-78517F Calcium Channel Type L, Dihydropyridine 86% 1.659uM 1.066uM View
calcium channel, voltage-dependent, beta 2 subunit TAMOXIFEN Calcium Channel Type L, Dihydropyridine 85% 8.585uM 5.519uM View
Cytochrom P450-1A2 monooxygenase NIFEDIPINE CYP450-1A2 Inhibition 85% .3uM NoneNone View
adrenergic receptor, alpha 2a ERGONOVINE Adrenergic alpha2A 85% 1.68uM .63uM View
dopamine receptor 2 ERGONOVINE Dopamine D2L 85% .552uM .184uM View
calcium channel, voltage-dependent, gamma subunit 8 CISAPRIDE Calcium Channel Type L, Benzothiazepine 85% .802uM .713uM View
calcium channel, voltage-dependent, gamma subunit 7 CISAPRIDE Calcium Channel Type L, Benzothiazepine 85% .802uM .713uM View
calcium channel, voltage-dependent, gamma subunit 6 CISAPRIDE Calcium Channel Type L, Benzothiazepine 85% .802uM .713uM View
calcium channel, voltage-dependent, gamma subunit 5 CISAPRIDE Calcium Channel Type L, Benzothiazepine 85% .802uM .713uM View
calcium channel, voltage-dependent, gamma subunit 4 CISAPRIDE Calcium Channel Type L, Benzothiazepine 85% .802uM .713uM View
calcium channel, voltage-dependent, gamma subunit 3 CISAPRIDE Calcium Channel Type L, Benzothiazepine 85% .802uM .713uM View
calcium channel, voltage-dependent, gamma subunit 2 CISAPRIDE Calcium Channel Type L, Benzothiazepine 85% .802uM .713uM View
calcium channel, voltage-dependent, gamma subunit 1 CISAPRIDE Calcium Channel Type L, Benzothiazepine 85% .802uM .713uM View
calcium channel, voltage-dependent, beta 4 subunit CISAPRIDE Calcium Channel Type L, Benzothiazepine 85% .802uM .713uM View
calcium channel, voltage-dependent, beta 3 subunit CISAPRIDE Calcium Channel Type L, Benzothiazepine 85% .802uM .713uM View
calcium channel, voltage-dependent, beta 2 subunit CISAPRIDE Calcium Channel Type L, Benzothiazepine 85% .802uM .713uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit CISAPRIDE Calcium Channel Type L, Benzothiazepine 85% .802uM .713uM View
calcium channel, voltage-dependent, alpha 1F subunit CISAPRIDE Calcium Channel Type L, Benzothiazepine 85% .802uM .713uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit CISAPRIDE Calcium Channel Type L, Benzothiazepine 85% .802uM .713uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit CISAPRIDE Calcium Channel Type L, Benzothiazepine 85% .802uM .713uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit CISAPRIDE Calcium Channel Type L, Benzothiazepine 85% .802uM .713uM View
calcium channel, voltage-dependent, beta 1 subunit CISAPRIDE Calcium Channel Type L, Benzothiazepine 85% .802uM .713uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit CISAPRIDE Calcium Channel Type L, Benzothiazepine 85% .802uM .713uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit CISAPRIDE Calcium Channel Type L, Benzothiazepine 85% .802uM .713uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 CISAPRIDE Calcium Channel Type L, Benzothiazepine 85% .802uM .713uM View
adrenergic receptor, alpha 2b CISAPRIDE Adrenergic alpha2C 85% .78uM .113uM View
adrenergic receptor, alpha 2c (Non-specific probe) CISAPRIDE Adrenergic alpha2C 85% .78uM .113uM View
5-hydroxytryptamine (serotonin) receptor 2C ATROPINE Serotonin 5-HT2C 85% 1.012uM .53uM View
Sigma-2 Receptor CLEMASTINE Sigma2 85% .728uM .448uM View
adrenergic receptor, alpha 2a CLOZAPINE Imidazoline I2, Central 85% .384uM .256uM View
adrenergic receptor, alpha 2c (Non-specific probe) CLOZAPINE Imidazoline I2, Central 85% .384uM .256uM View
Protein-tyrosine kinase, Fyn S(-)-CARBIDOPA Protein Tyrosine Kinase, Fyn 85% 3.731uM NoneNone View
opioid receptor, sigma 1 MOSAPRIDE Sigma1 85% .3056uM .1284uM View
dopamine receptor D3 MEPAZINE Dopamine D3 85% 2.006uM .681uM View
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 2-ACETYLAMINOFLUORENE Serotonin Transporter 85% 6.053uM 3.216uM View
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) 1-(2-FLUOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE CYP450-2C9 Inhibition 85% 2uM NoneNone View
cytochrome P450, family 2, subfamily C, polypeptide 9 1-(2-FLUOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE CYP450-2C9 Inhibition 85% 2uM NoneNone View
sodium channel, voltage-gated, type IV, alpha MEPAZINE Sodium Channel, Site 2 85% 2.521uM 2.3uM View
sodium channel, voltage-gated, type III, alpha MEPAZINE Sodium Channel, Site 2 85% 2.521uM 2.3uM View
sodium channel, voltage-gated, type II, beta MEPAZINE Sodium Channel, Site 2 85% 2.521uM 2.3uM View
sodium channel, voltage-gated, type II, alpha 2 MEPAZINE Sodium Channel, Site 2 85% 2.521uM 2.3uM View
sodium channel, voltage-gated, type I, beta MEPAZINE Sodium Channel, Site 2 85% 2.521uM 2.3uM View
sodium channel, voltage-gated, type I, alpha MEPAZINE Sodium Channel, Site 2 85% 2.521uM 2.3uM View
sodium channel, voltage-gated, type IV, beta MEPAZINE Sodium Channel, Site 2 85% 2.521uM 2.3uM View
sodium channel associated protein 1 MEPAZINE Sodium Channel, Site 2 85% 2.521uM 2.3uM View
sodium channel associated protein 2 MEPAZINE Sodium Channel, Site 2 85% 2.521uM 2.3uM View
sodium channel, voltage-gated, type III, beta MEPAZINE Sodium Channel, Site 2 85% 2.521uM 2.3uM View
sodium channel, voltage-gated, type I, alpha MEPAZINE Sodium Channel, Site 2 85% 2.521uM 2.3uM View
sodium channel, voltage-gated, type IX, alpha MEPAZINE Sodium Channel, Site 2 85% 2.521uM 2.3uM View
sodium channel, voltage-gated, type VII, alpha MEPAZINE Sodium Channel, Site 2 85% 2.521uM 2.3uM View
sodium channel, nonvoltage-gated 1 alpha PAROXETINE Sodium Channel, Site 2 85% 2.69uM 2.454uM View
sodium channel, voltage-gated, type X, alpha PAROXETINE Sodium Channel, Site 2 85% 2.69uM 2.454uM View
sodium channel, voltage-gated, type IX, alpha PAROXETINE Sodium Channel, Site 2 85% 2.69uM 2.454uM View
sodium channel, voltage gated, type VIII, alpha PAROXETINE Sodium Channel, Site 2 85% 2.69uM 2.454uM View
sodium channel, voltage-gated, type VII, alpha PAROXETINE Sodium Channel, Site 2 85% 2.69uM 2.454uM View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) PAROXETINE Sodium Channel, Site 2 85% 2.69uM 2.454uM View
sodium channel, voltage-gated, type IV, beta PAROXETINE Sodium Channel, Site 2 85% 2.69uM 2.454uM View
sodium channel, voltage-gated, type IV, alpha PAROXETINE Sodium Channel, Site 2 85% 2.69uM 2.454uM View
sodium channel, voltage-gated, type III, alpha PAROXETINE Sodium Channel, Site 2 85% 2.69uM 2.454uM View
sodium channel, voltage-gated, type II, beta PAROXETINE Sodium Channel, Site 2 85% 2.69uM 2.454uM View
sodium channel, voltage-gated, type II, alpha 2 PAROXETINE Sodium Channel, Site 2 85% 2.69uM 2.454uM View
sodium channel, voltage-gated, type I, beta PAROXETINE Sodium Channel, Site 2 85% 2.69uM 2.454uM View
sodium channel, voltage-gated, type I, alpha PAROXETINE Sodium Channel, Site 2 85% 2.69uM 2.454uM View
sodium channel, voltage-gated, type IV, beta PAROXETINE Sodium Channel, Site 2 85% 2.69uM 2.454uM View
sodium channel associated protein 1 PAROXETINE Sodium Channel, Site 2 85% 2.69uM 2.454uM View
sodium channel associated protein 2 PAROXETINE Sodium Channel, Site 2 85% 2.69uM 2.454uM View
sodium channel, voltage-gated, type III, beta PAROXETINE Sodium Channel, Site 2 85% 2.69uM 2.454uM View
sodium channel, voltage-gated, type I, alpha PAROXETINE Sodium Channel, Site 2 85% 2.69uM 2.454uM View
sodium channel, voltage-gated, type IX, alpha PAROXETINE Sodium Channel, Site 2 85% 2.69uM 2.454uM View
Sigma-2 Receptor PROCHLORPERAZINE Sigma2 85% .676uM .416uM View
adrenergic receptor, alpha 1a PERGOLIDE Adrenergic alpha1A 85% 1.93uM .781uM View
adrenergic receptor, beta 3 PINDOLOL Adrenergic beta3 85% .088uM .066uM View
androgen receptor FLUOROMETHOLONE Testosterone 85% 1.285uM .857uM View
calcium channel, voltage-dependent, gamma subunit 8 PIPAMAZINE Calcium Channel Type L, Phenylalkylamine 85% 1.941uM 1.887uM View
calcium channel, voltage-dependent, gamma subunit 7 PIPAMAZINE Calcium Channel Type L, Phenylalkylamine 85% 1.941uM 1.887uM View
calcium channel, voltage-dependent, gamma subunit 6 PIPAMAZINE Calcium Channel Type L, Phenylalkylamine 85% 1.941uM 1.887uM View
calcium channel, voltage-dependent, gamma subunit 5 PIPAMAZINE Calcium Channel Type L, Phenylalkylamine 85% 1.941uM 1.887uM View
calcium channel, voltage-dependent, gamma subunit 4 PIPAMAZINE Calcium Channel Type L, Phenylalkylamine 85% 1.941uM 1.887uM View
calcium channel, voltage-dependent, gamma subunit 3 PIPAMAZINE Calcium Channel Type L, Phenylalkylamine 85% 1.941uM 1.887uM View
calcium channel, voltage-dependent, gamma subunit 2 PIPAMAZINE Calcium Channel Type L, Phenylalkylamine 85% 1.941uM 1.887uM View
calcium channel, voltage-dependent, gamma subunit 1 PIPAMAZINE Calcium Channel Type L, Phenylalkylamine 85% 1.941uM 1.887uM View
calcium channel, voltage-dependent, beta 4 subunit PIPAMAZINE Calcium Channel Type L, Phenylalkylamine 85% 1.941uM 1.887uM View
calcium channel, voltage-dependent, beta 3 subunit PIPAMAZINE Calcium Channel Type L, Phenylalkylamine 85% 1.941uM 1.887uM View
calcium channel, voltage-dependent, beta 2 subunit PIPAMAZINE Calcium Channel Type L, Phenylalkylamine 85% 1.941uM 1.887uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit PIPAMAZINE Calcium Channel Type L, Phenylalkylamine 85% 1.941uM 1.887uM View
calcium channel, voltage-dependent, alpha 1F subunit PIPAMAZINE Calcium Channel Type L, Phenylalkylamine 85% 1.941uM 1.887uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit PIPAMAZINE Calcium Channel Type L, Phenylalkylamine 85% 1.941uM 1.887uM View
calcium channel, voltage-dependent, L type, alpha 1C subunit PIPAMAZINE Calcium Channel Type L, Phenylalkylamine 85% 1.941uM 1.887uM View
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit PIPAMAZINE Calcium Channel Type L, Phenylalkylamine 85% 1.941uM 1.887uM View
calcium channel, voltage-dependent, beta 1 subunit PIPAMAZINE Calcium Channel Type L, Phenylalkylamine 85% 1.941uM 1.887uM View
calcium channel, voltage-dependent, L type, alpha 1E subunit PIPAMAZINE Calcium Channel Type L, Phenylalkylamine 85% 1.941uM 1.887uM View
calcium channel, voltage-dependent, N type, alpha 1B subunit PIPAMAZINE Calcium Channel Type L, Phenylalkylamine 85% 1.941uM 1.887uM View
calcium channel, voltage-dependent, alpha2/delta subunit 1 PIPAMAZINE Calcium Channel Type L, Phenylalkylamine 85% 1.941uM 1.887uM View
Protein-tyrosine kinase, Fyn MICONAZOLE Protein Tyrosine Kinase, Fyn 85% 4.16uM NoneNone View
cholinergic receptor, muscarinic 3 DEXCHLORPHENIRAMINE Muscarinic M3 85% 2.579uM .547uM View
5-hydroxytryptamine (serotonin) receptor 2A DIETHYLSTILBESTROL Serotonin 5-HT2A 85% 4.79uM 1.369uM View
progesterone receptor DIETHYLSTILBESTROL Progesterone 85% 4.682uM .611uM View
progesterone receptor DIETHYLSTILBESTROL Progesterone 85% 4.682uM .611uM View
progesterone receptor ETHINYLESTRADIOL Progesterone 85% 1.067uM .139uM View
progesterone receptor ETHINYLESTRADIOL Progesterone 85% 1.067uM .139uM View
insulin receptor INSULIN Insulin 85% .001932uM .001816uM View
insulin receptor INSULIN Insulin 85% .001932uM .001816uM View
solute carrier family 28 (sodium-coupled nucleoside transporter), member 3 RAPAMYCIN Adenosine Transporter 85% 1.0848uM .3711uM View
concentrative Na+ nucleoside cotransporter (DBSS) RAPAMYCIN Adenosine Transporter 85% 1.0848uM .3711uM View
solute carrier family 28 (sodium-coupled nucleoside transporter), member 1 RAPAMYCIN Adenosine Transporter 85% 1.0848uM .3711uM View
adenine nucleotide translocase (DBSS) (Non-specific probe) RAPAMYCIN Adenosine Transporter 85% 1.0848uM .3711uM View
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4 RAPAMYCIN Adenosine Transporter 85% 1.0848uM .3711uM View
adrenergic receptor, alpha 2a AMITRIPTYLINE Imidazoline I2, Central 85% 1.685uM 1.123uM View
adrenergic receptor, alpha 2c (Non-specific probe) AMITRIPTYLINE Imidazoline I2, Central 85% 1.685uM 1.123uM View
adrenergic receptor, alpha 1d (Non-specific probe) AMITRIPTYLINE Adrenergic alpha1D 85% .105uM .052uM View
calcium channel, voltage-dependent, L type, alpha 1S subunit TAMOXIFEN Calcium Channel Type L, Dihydropyridine 85% 8.585uM 5.519uM View
calcium channel, voltage-dependent, alpha 1F subunit TAMOXIFEN Calcium Channel Type L, Dihydropyridine 85% 8.585uM 5.519uM View
calcium channel, voltage-dependent, L type, alpha 1D subunit TAMOXIFEN Calcium Channel Type L, Dihydropyridine 85% 8.585uM 5.519uM View